The present invention relates to a novel polymorph of omarigliptin, a process of preparing the same as well as a pharmaceutical composition comprising the same.La présente invention concerne un nouveau polymorphe domarigliptine, son procédé de préparation ainsi quune composition pharmaceutique le contenant.